Allogene Therapeutics Inc (ALLO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Allogene Therapeutics Inc-Aktie (ALLO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.76% 0.022	0.021	0.022	0.022	0.03
Operating Expenses	18.33% 69.53	85.13	63.02	80.56	99.12
Benefits Costs and Expenses	24.22% 65.02	85.80	-	-	100.00
Costs And Expenses	24.22% 65.02	85.80	63.02	80.56	100.00
Operating Income/Loss	18.34% -69.50	-85.11	-63.00	-80.54	-99.09
Nonoperating Income/Loss	773.24% 4.504	-0.669	0.709	1.308	-0.876
Income/Loss Before Equity Method Investments	-64.07	-	-	-	-
Income/Loss From Equity Method Investments	-0.929	-	-	-	-
Income/Loss From Continuing Operations Before Tax	24.22% -65.00	-85.78	0.022	0.022	-99.97
Income/Loss From Continuing Operations After Tax	24.22% -65.00	-85.78	-62.29	-79.23	-99.97
Net Income/Loss	24.22% -65.00	-85.78	-62.29	-79.23	-99.97
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4,299% 169.13	3.8443	167.65	146.80	144.56
Diluted Average Shares	4,299% 169.13	3.8443	167.65	146.80	144.56
Basic Earnings Per Share	25.49% -0.38	-0.51	-0.37	-0.54	-0.69
Diluted Earnings Per Share	25.49% -0.38	-0.51	-0.37	-0.54	-0.69
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$77.28

2.02%

SMMT

$20.39

2.15%

UTHR

$382.77

1.58%

MRNA

$53.29

0.47%

BGNE

$208.03

0.38%

BNTX

$110.97

1.84%